secwatch.observer — SEC 8-K summary
======================================

Issuer:     Rafael Holdings, Inc. (RFL)
CIK:        0001713863
Form:       8-K
Filed at:   2022-01-21T23:59:59+00:00
Accession:  0001213900-22-002935
Event type: leadership
Sentiment:  neutral
Materiality: 0.75
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Rafael Holdings appoints William Conkling as CEO, effective Feb 1, 2022
-----------------------------------------------------------------------

- William Conkling, former Chief Commercial & Business Officer, becomes CEO; Ameet Mallik remains on Board and chairs Transition Committee.
- Conkling receives $500K base salary, 50% target bonus, and 623,732 restricted shares vesting over 3+ years beginning Dec 21, 2022.
- CMO Mimi Huizinga departs Jan 31, 2022; Dr. Rick Ewing (ex-BMS) named Head of Drug Discovery.
- Shareholders elected all director nominees, ratified CohnReznick as auditor, and approved 2021 Equity Incentive Plan with 85.66% support.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1713863/000121390022002935/0001213900-22-002935-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1713863/000121390022002935/ea154267-8k_rafaelhold.htm
  HTML page:      https://secwatch.observer/filing/0001213900-22-002935

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer